In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder
V. Barth(Inserm), Jeffrey M. Witkin(St Vincent Hospital), Mark Wade(Salk Institute for Biological Studies), Bruno Giros(Centre National de la Recherche Scientifique), Scott D. Gleason(Inserm), Anne B. Need(Inserm), Eleni T. Tzavara(Inserm), Anna‐Karin Johansson(Inserm), C. Overshiner(Inserm), Kenneth W. Perry(Inserm), George G. Nomikos(Amgen (United Kingdom))
Cited by 32
Related Papers
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
|Brain Research|1991|865
Profound neuronal plasticity in response to inactivation of the dopamine transporter
|Proceedings of the National Academy of Sciences|1998|724